Clifford Chance has advised CITIC Securities as financial adviser to Sinopharm Common Wealth Company Limited. Sinopharm Common Wealth Company Limited, an investment consortium led by Sinopharm...
Sinopharm Group’s HK$15.6 Billion Privatization Of China TCM
Isola Castle Ltd’s Acquisition of Vinda Shares From Essity AB
Clifford Chance advised Essity AB on the deal. Linklaters acted for Royal Golden Eagle. Isola Castle Ltd, a company indirectly wholly owned by Asia Pacific Resources...
Chow Tai Fook Enterprises’ HK$35.5 Billion Cash Offer On NWS Holding
Clifford Chance advised NWS Holdings Limited on the deal. HONG Kong’s billionaire Cheng family offfered to buy the NWS Holdings shares that it does not own and...
Jin Jiang Capital’s Privatization
Baker McKenzie FenXun and Clifford Chance advised Jin Jiang International Holding Company Limited on the deal. Ashurst represented Orient Capital (Hong Kong) Limited and Nomura International...
China Huarong Asset Management’s US$6.6 Billion Recapitalisation
Clifford Chance advised China Huarong Asset Management Co., Ltd. on the deal. The strategic investment involves the issuance of 39,215,686,272 domestic shares and 1,960,784,313 H shares...
China International Capital Corporation Hong Kong Securities Limited’s Merger with China Machinery Engineering Corporation
Baker McKenzie has advised China International Capital Corporation Hong Kong Securities Limited on the deal. Clifford Chance has advised China Machinery Engineering Corporation. King & Wood...
Beijing Capital Group Co., Ltd.’s US$681 Million Privatisation Of Beijing Capital Land Ltd.
Slaughter and May advised China International Capital Corporation Hong Kong Securities Limited on the deal. Norton Rose Fulbright advised Beijing Capital Land Ltd. Clifford Chance advised...